CoChat

Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD) is an age-associated neurodegenerative disease characterized by amyloidosis, tauopathy, and activation of microglia, the brain resident innate immune cells. We show that a RiboTag translational profiling approach can bypass biases due to cellular enrichment/cell sorting. Using this approach in models of amyloidosis, tauopathy, and aging, we revealed a common set of alterations and identified a central APOE-driven network that converged on CCL3 and CCL4 across all conditions. Notably, aged females demonstrated a significant exacerbation of many of these shared transcripts in this APOE network, revealing a potential mechanism for increased AD susceptibility in females. This study has broad implications for microglial transcriptomic approaches and provides new insights into microglial pathways associated with different pathological aspects of aging and AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20180653

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Transcript isolation methodology can introduce bias in microglial transcriptomes. (A) Rpl22HA RiboTag model expressing an alternative HA epitope tagged Rpl22 exon 4. (B) Cell-type specific promoter driven Cre expression uniquely express HA-tagged RPL22 for mRNA transcript purification at “time zero” without necessity for cellular purification. (C) Tamoxifen-treated Cx3cr1CreERT2-IRES-eYFP/+; Rpl22HA/+ mice were injected with saline or 2 mg/kg LPS i.p. and harvested at 24 h for generation of microglial RNAseq of mRNA purified by RiboTag or by cellular isolation by enzymatic digestion, Percoll gradient myelin removal, staining, and flow cytometric sorting forlive 7AAD− CD11b+ CD45lo/int microglia. PCA of microglial RNAseq transcriptomes with centroids. n = 3–4 per group from one independent experiment. (D) Fold enrichment of RiboTag and cellular isolation methods relative to input by RNAseq for microglial (micro; red), astrocytes (astro; blue), neurons (neuron; orange), oligodendrocytes (oligo; yellow), and endothelial (endo; purple) transcripts. Shown are the averages ± SEM, n = 3–4 per group from one independent experiment. (E) Top 20 most abundant microglial transcripts enriched in cellular isolation (>10-fold enriched over input) with >10-fold overexpression relative to RiboTag transcripts shown as averages ± SEMwith FDR set at q < 0.1. n = 3–4 per group from one independent experiment. (F) Flow plot of TMEM119+ CD11b+ Live Zombie− microglia with S100A8 (red) or fluorescence minus one control (FMO ctrl; blue). n = 3 per group, two independent experiments. (G–J) Average RPKM value ± SEM from RNAseq. n = 3–4 per group, one independent experiment for Lcn2 (G), Il1b (H), Prok2 (I), and Cst7 (J), two-way ANOVA with Tukey posthoc t tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Numbers in parentheses indicate fold induction.
Figure 1. Transcript isolation methodology can introduce bias in microglial transcriptomes. (A) Rpl22HA RiboTag model expressing an alternative HA epitope tagged Rpl22 exon 4. (B) Cell-type specific promoter driven Cre expression uniquely express HA-tagged RPL22 for mRNA transcript purification at “time zero” without necessity for cellular purification. (C) Tamoxifen-treated Cx3cr1CreERT2-IRES-eYFP/+; Rpl22HA/+ mice were injected with saline or 2 mg/kg LPS i.p. and harvested at 24 h for generation of microglial RNAseq of mRNA purified by RiboTag or by cellular isolation by enzymatic digestion, Percoll gradient myelin removal, staining, and flow cytometric sorting forlive 7AAD− CD11b+ CD45lo/int microglia. PCA of microglial RNAseq transcriptomes with centroids. n = 3–4 per group from one independent experiment. (D) Fold enrichment of RiboTag and cellular isolation methods relative to input by RNAseq for microglial (micro; red), astrocytes (astro; blue), neurons (neuron; orange), oligodendrocytes (oligo; yellow), and endothelial (endo; purple) transcripts. Shown are the averages ± SEM, n = 3–4 per group from one independent experiment. (E) Top 20 most abundant microglial transcripts enriched in cellular isolation (>10-fold enriched over input) with >10-fold overexpression relative to RiboTag transcripts shown as averages ± SEMwith FDR set at q < 0.1. n = 3–4 per group from one independent experiment. (F) Flow plot of TMEM119+ CD11b+ Live Zombie− microglia with S100A8 (red) or fluorescence minus one control (FMO ctrl; blue). n = 3 per group, two independent experiments. (G–J) Average RPKM value ± SEM from RNAseq. n = 3–4 per group, one independent experiment for Lcn2 (G), Il1b (H), Prok2 (I), and Cst7 (J), two-way ANOVA with Tukey posthoc t tests. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Numbers in parentheses indicate fold induction.CC BY-NC-SA · PubMed Central
Figure 2. Translational ribosomal profiling of microglial transcriptomes reveals amyloidosis and tauopathy responses overlap with aging but are mostly distinct from acute inflammation. RiboTag derived microglial transcripts from aged (24-mo-old) mice, 9–10-mo-old APP/PS1, and 9–10-mo old rAAV-TauP301L Tau male mice were examined by RNAseq. (A–E) PCA with centroids of RNAseq datasets of microglial transcriptomes from either aged (A), APP/PS1 (B), rAAV-TauP301L (C), 2 mg/kg LPS-injected mice 24 h after challenge (D), and 12 mg/kg poly(I:C)-injected mice 24 h after challenge (E) versus controls were generated from n = 3–5 animals per group, one independent experiment. (F–J) Top 25 changes in microglial transcripts (FDR q < 0.1; FC > 1.25) ranked by age (F), APP/PS1 (G), Tau (H), LPS (I), and poly(I:C) (J). Scale on heat map is log2 fold change n = 3–5 animals per group, one independent experiment. Black boxes indicate that the transcript did not meet the cutoff of q < 0.1 and absolute FC ≥ 1.25.
Figure 2. Translational ribosomal profiling of microglial transcriptomes reveals amyloidosis and tauopathy responses overlap with aging but are mostly distinct from acute inflammation. RiboTag derived microglial transcripts from aged (24-mo-old) mice, 9–10-mo-old APP/PS1, and 9–10-mo old rAAV-TauP301L Tau male mice were examined by RNAseq. (A–E) PCA with centroids of RNAseq datasets of microglial transcriptomes from either aged (A), APP/PS1 (B), rAAV-TauP301L (C), 2 mg/kg LPS-injected mice 24 h after challenge (D), and 12 mg/kg poly(I:C)-injected mice 24 h after challenge (E) versus controls were generated from n = 3–5 animals per group, one independent experiment. (F–J) Top 25 changes in microglial transcripts (FDR q < 0.1; FC > 1.25) ranked by age (F), APP/PS1 (G), Tau (H), LPS (I), and poly(I:C) (J). Scale on heat map is log2 fold change n = 3–5 animals per group, one independent experiment. Black boxes indicate that the transcript did not meet the cutoff of q < 0.1 and absolute FC ≥ 1.25.CC BY-NC-SA · PubMed Central
Figure 3. Microglial transcripts shared between aging, amyloidosis, and tauopathy form significant biological pathways. Volcano plots of microglial RiboTag isolated transcripts altered in aged (24 mo old; A), APP/PS1 (B), and rAAV-TauP301L (C). Red are FC values > 0; blue are FC values < 0. Black are transcripts that did not reach significance. The dashed lines indicate an FDR q > 0.1 (considered nonsignificant) based on n = 4–5 animals per group, one independent RNAseq experiment. (D) The fold up-regulation of the top 25 shared genes, sorted by the aged dataset, as averages ± SEM (n = 4–5 per group, one independent experiment). Dashed line, fold change of 1 (no change). (E) Cst7 expression following Cst7 siRNA mediated knockdown. Shown are averages ± SEM (n = 4 per group). Three independent experiments were performed. (F) Fluorescent sphere phagocytosis by primary microglia with siRNA mediated Cst7 knockdown compared with control siRNA. Shown are averages ± SEM (n = 4 per group); **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by one-way ANOVA, Tukey’s posthoc. Three independent experiments were performed. (G) Significant biological pathways by gene ontology (DAVID; NIAID/NIH) for shared microglial transcripts between aging, amyloidosis, and tauopathy.
Figure 3. Microglial transcripts shared between aging, amyloidosis, and tauopathy form significant biological pathways. Volcano plots of microglial RiboTag isolated transcripts altered in aged (24 mo old; A), APP/PS1 (B), and rAAV-TauP301L (C). Red are FC values > 0; blue are FC values < 0. Black are transcripts that did not reach significance. The dashed lines indicate an FDR q > 0.1 (considered nonsignificant) based on n = 4–5 animals per group, one independent RNAseq experiment. (D) The fold up-regulation of the top 25 shared genes, sorted by the aged dataset, as averages ± SEM (n = 4–5 per group, one independent experiment). Dashed line, fold change of 1 (no change). (E) Cst7 expression following Cst7 siRNA mediated knockdown. Shown are averages ± SEM (n = 4 per group). Three independent experiments were performed. (F) Fluorescent sphere phagocytosis by primary microglia with siRNA mediated Cst7 knockdown compared with control siRNA. Shown are averages ± SEM (n = 4 per group); **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by one-way ANOVA, Tukey’s posthoc. Three independent experiments were performed. (G) Significant biological pathways by gene ontology (DAVID; NIAID/NIH) for shared microglial transcripts between aging, amyloidosis, and tauopathy.CC BY-NC-SA · PubMed Central
Figure 4. Microglial APOE drives the top network formed by shared microglial transcripts between aging, amyloidosis, and tauopathy. (A–D) RPKM versus abundance ranking of microglial transcripts in aged (24 mo old; A), APP/PS1 (B), Tau (C), and young 3-mo-old males (D) based on n = 4–5 animals per group, one independent RNAseq experiment. (E–G) Relative ApoE microglial mRNA up-regulation in aged (24 mo old; E), APP (F), and Tau (G) versus respective controls. Shown are averages ± SEM (n = 4–5 per group, one independent experiment); ***, P < 0.001, ****, P < 0.0001 by unpaired two-tailed Student’s t test. (H) Ingenuity network analysis of the shared transcripts between aging, amyloidosis, and tauopathy with FDR set at q < 0.1 and absolute FC > 1.25. (I) SPP1 geometric mean fluorescence intensity (GMFI) by flow cytometric analysis of live TMEM119+CD11b+ microglia between WT and Apoe−/− mice shown as averages ± SEM; **, P < 0.01 unpaired two-tailed Student’s t test, n = 3–5 animals per group, two independent experiments.
Figure 4. Microglial APOE drives the top network formed by shared microglial transcripts between aging, amyloidosis, and tauopathy. (A–D) RPKM versus abundance ranking of microglial transcripts in aged (24 mo old; A), APP/PS1 (B), Tau (C), and young 3-mo-old males (D) based on n = 4–5 animals per group, one independent RNAseq experiment. (E–G) Relative ApoE microglial mRNA up-regulation in aged (24 mo old; E), APP (F), and Tau (G) versus respective controls. Shown are averages ± SEM (n = 4–5 per group, one independent experiment); ***, P < 0.001, ****, P < 0.0001 by unpaired two-tailed Student’s t test. (H) Ingenuity network analysis of the shared transcripts between aging, amyloidosis, and tauopathy with FDR set at q < 0.1 and absolute FC > 1.25. (I) SPP1 geometric mean fluorescence intensity (GMFI) by flow cytometric analysis of live TMEM119+CD11b+ microglia between WT and Apoe−/− mice shown as averages ± SEM; **, P < 0.01 unpaired two-tailed Student’s t test, n = 3–5 animals per group, two independent experiments.CC BY-NC-SA · PubMed Central
Figure 5. Age related sex differences reveal exacerbation of numerous transcripts involved in the APOE-driven network of CCL3 and CCL4 production. Tamoxifen injected Cx3Cr1CreER/+; Rpl22HA/+ (“RiboTag”) male and female mice were analyzed by RNAseq at 3, 12, and 24 mo of age with FDR set at q < 0.1 and FC > 1.25. (A) PCA of microglial transcriptomes from 3-mo-old males and females, 12-mo-old males and females, and 24-mo-old males and females were generated from n = 4–5 animals per group, one independent experiment. (B–D) Female microglial transcripts at 3 mo (B), 12 mo (C), and 24 mo (D) that were significantly up-regulated compared with male transcripts from the corresponding age. Data are shown for each age as an average ± SEM for n = 4–5 mice per group, one independent experiment. (E) Examination of the top 25 up-regulated transcripts in aged (24-mo-old) females versus young (3-mo-old) females were shown relative to alterations observed in 12-mo versus 3-mo-old females, 24-mo versus 3-mo-old males, and 12-mo versus 3-mo-old males. Shown is the average fold up-regulation ± SEM for n = 4–5 mice per group, one independent RNA seq experiment. (F) Transcripts significantly altered by sex in aged, 24-mo-old mice, observed in the APOE-driven pathway. M is male, F is female. Bar graphs are averages ± SEM; ***, P < 0.001; ****, P < 0.0001 unpaired two-tailed Student’s t test (n = 4–5 per group, one independent experiment).
Figure 5. Age related sex differences reveal exacerbation of numerous transcripts involved in the APOE-driven network of CCL3 and CCL4 production. Tamoxifen injected Cx3Cr1CreER/+; Rpl22HA/+ (“RiboTag”) male and female mice were analyzed by RNAseq at 3, 12, and 24 mo of age with FDR set at q < 0.1 and FC > 1.25. (A) PCA of microglial transcriptomes from 3-mo-old males and females, 12-mo-old males and females, and 24-mo-old males and females were generated from n = 4–5 animals per group, one independent experiment. (B–D) Female microglial transcripts at 3 mo (B), 12 mo (C), and 24 mo (D) that were significantly up-regulated compared with male transcripts from the corresponding age. Data are shown for each age as an average ± SEM for n = 4–5 mice per group, one independent experiment. (E) Examination of the top 25 up-regulated transcripts in aged (24-mo-old) females versus young (3-mo-old) females were shown relative to alterations observed in 12-mo versus 3-mo-old females, 24-mo versus 3-mo-old males, and 12-mo versus 3-mo-old males. Shown is the average fold up-regulation ± SEM for n = 4–5 mice per group, one independent RNA seq experiment. (F) Transcripts significantly altered by sex in aged, 24-mo-old mice, observed in the APOE-driven pathway. M is male, F is female. Bar graphs are averages ± SEM; ***, P < 0.001; ****, P < 0.0001 unpaired two-tailed Student’s t test (n = 4–5 per group, one independent experiment).CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

    Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×

    “Microglia, the central nervous system (CNS)–resident innate immune population, are central cellular mediators during homeostasis and disease (Davalos et al., 2005; Nimmerjahn et al., 2005; Saijo and Glass, 2011; Nayak et al., 2014).”
    Background
  • A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

    Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 3×

    “3, E and F), suggesting that Cst7 induction in microglial cells may contribute to the decreased phagocytic activity observed during amyloidosis, tauopathy, or aging (Krabbe et al., 2013; Keren-Shaul et al., 2017; Koellhoffer et al., 2017; Salter and Stevens, 2017).”
    Background
  • ATP mediates rapid microglial response to local brain injury in vivo

    Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 2×

    “We hypothesized that microglial cellular isolation strategies may introduce unwanted bias, as has recently been reported for muscle stem cell populations (Davalos et al., 2005; Nayak et al., 2014; van den Brink et al., 2017).”
    Background
  • Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

    Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 2×

    “Illuminating microglial transcriptome alterations during disease conditions is critical since genome-wide association studies have also identified several human genetic AD risk alleles that likely modulate microglial function including CR1, CD33, TREM2, and APOE (Corneveaux et al., 2010; Guerreiro et al., 2013; Liu et…”
    Background
  • TREM2 Variants in Alzheimer's Disease

    Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020

  • Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor

    Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599 · cited 3×

    “Comparison of RiboTag versus cell enrichment with sorting (referred to generally here as “cellular isolation”) methodologies for microglial transcript isolation was conducted in tamoxifen injected RiboTag mice, which induced Cx3cr1-YFP+-HA+ cells (Fig. S1 I; Parkhurst et al., 2013).”
    BackgroundMethod
  • Long-term cognitive impairment and functional disability among survivors of severe sepsis.

    Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582 · cited 1×

    “Additionally, sepsis, which can result in CNS neutrophil recruitment, has also been associated with cognitive decline (Iwashyna et al., 2010; He et al., 2016).”
    Background
  • Microglia emerge as central players in brain disease

    Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767 · cited 1×

    “3, E and F), suggesting that Cst7 induction in microglial cells may contribute to the decreased phagocytic activity observed during amyloidosis, tauopathy, or aging (Krabbe et al., 2013; Keren-Shaul et al., 2017; Koellhoffer et al., 2017; Salter and Stevens, 2017).”
    Background
  • The microglial sensome revealed by direct RNA sequencing

    Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · cited 1×

    “Alzheimer’s disease (AD) is the leading form of dementia, marked by key pathological features of extracellular amyloid plaque deposition and intracellular neurofibrillary tangles composed of hyperphosphorylated tau (Holtzman et al., 2011).”
    Background
  • Alzheimer’s Disease: The Challenge of the Second Century

    Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · cited 1×

    “Alzheimer’s disease (AD) is the leading form of dementia, marked by key pathological features of extracellular amyloid plaque deposition and intracellular neurofibrillary tangles composed of hyperphosphorylated tau (Holtzman et al., 2011).”
    Background

Show all 32 references

Cited by

Items 201–270 of 270

Metadata

Authors
Kang, S. S., Ebbert, M. T. W., Baker, K. E., Cook, C., Wang, X., Sens, J. P., Kocher, J.-P., Petrucelli, L., & Fryer, J. D.
Affiliations
  • Mayo Clinic in Florida (US)
  • Mayo Clinic (US)
Corresponding author
  • Kang, Silvia S.
  • Fryer, John D.
Venue
Journal of Experimental Medicine
Published
2018-08-06
Volume
215
Issue
9
Pages
2235-2245
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2885498250
Cited by
260
References
32
Citations by year
2026: 19 · 2025: 23 · 2024: 42 · 2023: 39 · 2022: 49 · 2021: 34 · 2020: 28 · 2019: 23 · 2018: 3
FWCI
9.90
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Mayo Foundation
  • GHR Foundation
  • Mayo Clinic
  • Florida Department of Health (6AZ06)
  • National Institutes of Health (NS094137, AG047327, AG049992, MH103632, AG057997, AG016574, NS100693, NS097273, NS084974)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, microglia, apolipoprotein E, translational profiling, RiboTag, amyloidosis, tauopathy, aging, CCL3, carbon tetrachloride, sex differences, female susceptibility, microglial transcriptome, neuroinflammation
MeSH terms
Aging, Alzheimer Disease, Amyloid, Amyloidosis, Animals, Apolipoproteins E, Disease Models, Animal, Female, Male, Mice, Transgenic, Signal Transduction, tau Proteins, Microglia, Mice, Chemokine CCL3, Chemokine CCL4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.